Frederique Ph.d. Menzaghi
VP-Research & Development, Tvardi Therapeutics, Inc.
Companies
- Tvardi Therapeutics, Inc.VP-Research & Development Jan 30, 2014 to Feb 5, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tvardi Therapeutics, Inc. TVRD167,247 shares2$166.2K at $0.99Feb 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 1, 2024Granted 13,500 shares of Tvardi Therapeutics, Inc.2
- Jun 23, 2023Sold 2,993 shares at $3.51 of Tvardi Therapeutics, Inc.3
- Apr 4, 2023Sold 2,733 shares at $4.91 of Tvardi Therapeutics, Inc.4
- Mar 3, 2023Sold 6,802 shares at $9.71 of Tvardi Therapeutics, Inc.5
- Dec 21, 2022Sold 3,506 shares at $11.27 of Tvardi Therapeutics, Inc.6
- Apr 1, 2022Sold 1,784 shares at $11.91 of Tvardi Therapeutics, Inc.7
- Feb 25, 2022Sold 2,114 shares at $10.29 of Tvardi Therapeutics, Inc.8
- Feb 25, 2022Granted 20,000 shares of Tvardi Therapeutics, Inc.8
- Dec 17, 2021Granted 12,607 shares of Tvardi Therapeutics, Inc.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Jun 27, 2023
- 4SEC EDGARForm 4 filed Apr 6, 2023
- 5SEC EDGARForm 4 filed Mar 7, 2023
- 6SEC EDGARForm 4 filed Dec 23, 2022
- 7SEC EDGARForm 4 filed Apr 5, 2022
- 8SEC EDGARForm 4 filed Mar 1, 2022
- 9SEC EDGARForm 4 filed Dec 21, 2021